Trial intelligence / Profile preview

Beclometasone nebulization versus placebo for moderate croup in young children

2009-014376-22Phase 3Terminated

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in croup comparing Beclometasone dipropionate with Placebo (2 arms). Primary endpoint: Change in Westley croup score at 6 hours. Started Nov 2009; status: terminated.

02

Drugs

beclomethasone dipropionate
03

Conditions

croup

Beyond the preview

Go deeper on 2009-014376-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014376-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call